| Stock | PriceCurrent trading price. | Market CapTotal market capitalization. | FKPrice to Earnings ratio. | PD/DDPrice to Book ratio. | EV/EBITDAEnterprise Value / EBITDA. | ROICReturn on Invested Capital. | WACCWeighted Average Cost of Capital (WACC). | PUSLAFinancial health score (0-100). | DamodaranValuation score. | Intrinsic ValueFair value via DCF model. | Potential %Expected upside potential %. | Dalio RiskDalio Debt Cycle Score | Debt/EquityDebt to Equity ratio. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
AAK
|
191.80 | 49.8B | 3.44 | 2.47 | 2.38 | 14.8% | 8.8% | 77 | 70 | 328.00 | +53.3% | 72 | 0.29 |
|
CLA_B
|
55.25 | 15.6B | 4.58 | 2.73 | 3.17 | 13.2% | 9.3% | 74 | 63 | 90.16 | +47.4% | 72 | 0.31 |
|
HUMBLE
|
5.37 | 2.4B | — | 0.54 | 2.50 | 3.2% | 7.3% | 74 | 65 | 13.17 | +107.5% | 64 | 0.54 |
|
VIVA
|
38.20 | 3.4B | 4.14 | 2.08 | 2.68 | 8.3% | 8.7% | 72 | 65 | 69.18 | +60.8% | 63 | 0.88 |
|
SCST
|
145.60 | 10.0B | 5.75 | 3.32 | 3.21 | 9.7% | 8.6% | 50 | 30 | 135.76 | -4.9% | 63 | 0.88 |
The Lothien health scores and analyses on this page are for informational purposes only. They do not constitute investment advice. Please consult a licensed investment advisor before making investment decisions.